- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Key Metrics
- Market Cap (In Cr) 60842.48
- Beta 0.95
- Div. Yield (%) 0.28
- P/B 10.82
- TTM P/E 75.07
- Peg Ratio 5.51
- Sector P/E 39.92
- D/E 0.67
- Open Price 4235.1
- Prev Close 4233
Analysis
-
1 Week0.17%
-
3 Months-3.72%
-
6 Month-3.74%
-
YTD-5.5%
-
1 Year-9.32%
- 25% Low risk
- 25% Moderate risk
- 25% Balanced Risk
- 25% High risk
- 25% Extreme risk
22 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
- Ratings
- Current
- Strong Sell
- 0
- Sell
- 0
- Hold
- 0
- Buy
- 13
- Strong Buy
- 9
Apollo Hospitals Enterprise News
Indices end with minor gains, Sensex up 90 pts; Bank, Media shine
29 min read . 23 Nov 2022'Rakesh Jhunjhunwala's most valuable and profitable investment advice ever…'
1 min read . 23 Aug 2022₹12 to ₹4,124: Multibagger stock turns ₹1 lakh to ₹3.24 Cr in 23 years
5 min read . 21 Aug 2022Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 14662.6
- Selling/ General/ Admin Expenses Total
- 4882.5
- Depreciation/ Amortization
- 600.1
- Other Operating Expenses Total
- 17.5
- Total Operating Expense
- 12780.1
- Operating Income
- 1882.5
- Net Income Before Taxes
- 1578.1
- Net Income
- 1055.6
- Diluted Normalized EPS
- 59.34
- Period
- 2022
- Total Assets
- 13218.13
- Total Liabilities
- 7595.03
- Total Equity
- 5623.1
- Tangible Book Valueper Share Common Eq
- 318.21
- Period
- 2022
- Cashfrom Operating Activities
- 1728.6
- Cashfrom Investing Activities
- -778.2
- Cashfrom Financing Activities
- -792.6
- Net Changein Cash
- 157.8
- Period
- 2021
- Total Revenue
- 10560
- Selling/ General/ Admin Expenses Total
- 3663.8
- Depreciation/ Amortization
- 572.5
- Other Operating Expenses Total
- 71.7
- Total Operating Expense
- 9932.2
- Operating Income
- 627.8
- Net Income Before Taxes
- 220.7
- Net Income
- 150.4
- Diluted Normalized EPS
- 8.2
- Period
- 2021
- Total Assets
- 11416.7
- Total Liabilities
- 6814.2
- Total Equity
- 4602.5
- Tangible Book Valueper Share Common Eq
- 288.02
- Period
- 2021
- Cashfrom Operating Activities
- 1256.9
- Cashfrom Investing Activities
- -872.3
- Cashfrom Financing Activities
- -340.1
- Net Changein Cash
- 44.5
- Period
- 2020
- Total Revenue
- 11246.8
- Selling/ General/ Admin Expenses Total
- 4117.4
- Depreciation/ Amortization
- 619.1
- Other Operating Expenses Total
- 39.5
- Total Operating Expense
- 10077.2
- Operating Income
- 1169.6
- Net Income Before Taxes
- 660
- Net Income
- 454.8
- Diluted Normalized EPS
- 23.48
- Period
- 2020
- Total Assets
- 11338.4
- Total Liabilities
- 7999.3
- Total Equity
- 3339.1
- Tangible Book Valueper Share Common Eq
- 211.19
- Period
- 2020
- Cashfrom Operating Activities
- 1292.8
- Cashfrom Investing Activities
- -288.8
- Cashfrom Financing Activities
- -909.5
- Net Changein Cash
- 94.5
- Period
- 2019
- Total Revenue
- 9617.44
- Selling/ General/ Admin Expenses Total
- 3831.59
- Depreciation/ Amortization
- 394.91
- Other Operating Expenses Total
- 52.06
- Total Operating Expense
- 8940.04
- Operating Income
- 677.4
- Net Income Before Taxes
- 373.54
- Net Income
- 236.05
- Diluted Normalized EPS
- 17.02
- Period
- 2019
- Total Assets
- 9183.07
- Total Liabilities
- 5849.6
- Total Equity
- 3333.47
- Tangible Book Valueper Share Common Eq
- 212.2
- Period
- 2019
- Cashfrom Operating Activities
- 904.95
- Cashfrom Investing Activities
- -710.56
- Cashfrom Financing Activities
- -214.51
- Net Changein Cash
- -20.12
- Period
- 2018
- Total Revenue
- 8243.47
- Selling/ General/ Admin Expenses Total
- 3364.7
- Depreciation/ Amortization
- 358.41
- Other Operating Expenses Total
- 42.33
- Total Operating Expense
- 7798.72
- Operating Income
- 444.74
- Net Income Before Taxes
- 171.46
- Net Income
- 117.42
- Diluted Normalized EPS
- 8.81
- Period
- 2018
- Total Assets
- 8612.83
- Total Liabilities
- 5361.32
- Total Equity
- 3251.5
- Tangible Book Valueper Share Common Eq
- 205.88
- Period
- 2018
- Cashfrom Operating Activities
- 536.96
- Cashfrom Investing Activities
- -404.91
- Cashfrom Financing Activities
- -108.5
- Net Changein Cash
- 23.55
- Period
- 2017
- Total Revenue
- 7255.7
- Selling/ General/ Admin Expenses Total
- 2891.26
- Depreciation/ Amortization
- 313.42
- Other Operating Expenses Total
- 24.74
- Total Operating Expense
- 6828.91
- Operating Income
- 426.79
- Net Income Before Taxes
- 222.08
- Net Income
- 220.99
- Diluted Normalized EPS
- 16.08
- Period
- 2017
- Total Assets
- 8119.29
- Total Liabilities
- 4806.08
- Total Equity
- 3313.2
- Tangible Book Valueper Share Common Eq
- 211.26
- Period
- 2017
- Cashfrom Operating Activities
- 622.55
- Cashfrom Investing Activities
- -1151.88
- Cashfrom Financing Activities
- 476.96
- Net Changein Cash
- -52.37
- Period
- 2022-09-30
- Total Revenue
- 4251.07
- Selling/ General/ Admin Expenses Total
- 540.84
- Depreciation/ Amortization
- 155.01
- Other Operating Expenses Total
- 973
- Total Operating Expense
- 3840.71
- Operating Income
- 410.36
- Net Income Before Taxes
- 327.07
- Net Income
- 203.99
- Diluted Normalized EPS
- 14.19
- Period
- 2022-09-30
- Total Assets
- 13974.84
- Total Liabilities
- 7981.97
- Total Equity
- 5992.87
- Tangible Book Valueper Share Common Eq
- 344.25
- Period
- 2022-09-30
- Period
- 2022-06-30
- Total Revenue
- 3795.6
- Selling/ General/ Admin Expenses Total
- 447.42
- Depreciation/ Amortization
- 147.78
- Other Operating Expenses Total
- 905.32
- Total Operating Expense
- 3452.64
- Operating Income
- 342.96
- Net Income Before Taxes
- 254.28
- Net Income
- 317.11
- Diluted Normalized EPS
- 22.05
- Period
- 2022-06-30
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 3546.39
- Selling/ General/ Admin Expenses Total
- 446.6
- Depreciation/ Amortization
- 166.4
- Other Operating Expenses Total
- 820.89
- Total Operating Expense
- 3249.59
- Operating Income
- 296.8
- Net Income Before Taxes
- 232.72
- Net Income
- 90.12
- Diluted Normalized EPS
- 6.27
- Period
- 2022-03-31
- Total Assets
- 13218.13
- Total Liabilities
- 7595.03
- Total Equity
- 5623.1
- Tangible Book Valueper Share Common Eq
- 318.21
- Period
- 2022-03-31
- Period
- 2021-12-31
- Total Revenue
- 3638.93
- Selling/ General/ Admin Expenses Total
- 439.6
- Depreciation/ Amortization
- 148.99
- Other Operating Expenses Total
- 788.78
- Total Operating Expense
- 3200.9
- Operating Income
- 438.03
- Net Income Before Taxes
- 361.51
- Net Income
- 228.37
- Diluted Normalized EPS
- 15.88
- Period
- 2021-12-31
- Period
- 2021-12-31
- Period
- 2021-09-30
- Total Revenue
- 3717.07
- Selling/ General/ Admin Expenses Total
- 456.82
- Depreciation/ Amortization
- 144.76
- Other Operating Expenses Total
- 772.93
- Total Operating Expense
- 3246.84
- Operating Income
- 470.23
- Net Income Before Taxes
- 380.47
- Net Income
- 247.82
- Diluted Normalized EPS
- 17.24
- Period
- 2021-09-30
- Total Assets
- 12910.09
- Total Liabilities
- 7605.42
- Total Equity
- 5304.67
- Tangible Book Valueper Share Common Eq
- 297.01
- Period
- 2021-09-30
Forecast
Forecast
Forecast
Technical
- 5 Day4247.65
- 10 Day4270.77
- 20 Day4320.66
- 50 Day4530.78
- 100 Day4467.25
- 300 Day4257.37
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Apollo Hospitals Enterprise
- 4245.2
- 12.2
- 0.29
- 5015.45
- 3365.9
- 61290.37
- Max Healthcare Institute
- 436.4
- -4
- -0.91
- 482.5
- 306
- 42833.26
- Fortis Healthcare
- 278
- -0.3
- -0.11
- 324.8
- 219.8
- 20987.84
- Dr. Lal Pathlabs
- 1890.1
- -129.8
- -6.43
- 3270.3
- 1805.1
- 17012.09
- Narayana Hrudayalaya
- 715.15
- -6.35
- -0.88
- 810.15
- 589.9
- 14461.62
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Apollo Hospitals Enterprise
- 71.84
- 10.9
- 10.6
- 3.56
- Max Healthcare Institute
- 69.55
- 6.81
- -
- -
- Fortis Healthcare
- 69.86
- 3.4
- -2.77
- -1.42
- Dr. Lal Pathlabs
- 49.31
- 11.26
- 24.34
- 17.17
- Narayana Hrudayalaya
- 42
- 9.78
- 9.95
- 3.83
Shareholding
- Category
- Percentage
- No. of shares
- Public Shareholding
- 70.67%
- 101,607,045
- SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES
- 1.9%
- 2,737,719
- VERITAS FUNDS PLC ON BEHALF OF VERITAS ASIAN FUND
- 1.41%
- 2,024,329
- TOUCHSTONE STRATEGIC TRUST - TOUCHSTONE SANDS CAPITAL EMERGING MARKETS GROWTH FUND
- 1.3%
- 1,865,136
- JP MORGAN FUNDS
- 1.05%
- 1,516,901
- Others
- 39.23%
- 56,401,282
- AXIS MUTUAL FUND TRUSTEE LIMITED
- 1.65%
- 2,373,570
- SBI NIFTY 50 ETF
- 1.64%
- 2,363,410
- ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED
- 1.54%
- 2,208,283
- HDFC TRUSTEE COMPANY LIMITED
- 1.16%
- 1,666,242
- Others
- 4.2%
- 6,055,055
- LIFE INSURANCE CORPORATION OF INDIA
- 2%
- 2,881,613
- HDFC LIFE INSURANCE COMPANY LIMITED
- 1.02%
- 1,460,752
- Others
- 2.49%
- 3,594,803
- Others
- 3.89%
- 5,589,931
- Others
- 3.05%
- 4,381,680
- Others
- 0.81%
- 1,167,569
- Others
- 0.7%
- 1,001,848
- Bodies Corporate
- 0.34%
- 487,987
- Clearing Members
- 0.1%
- 145,218
- Trusts
- 0.1%
- 138,367
- Unclaimed or Suspense or Escrow Account
- 0.09%
- 132,396
- HUF
- 0.05%
- 66,149
- LLP
- 0.01%
- 15,995
- Foreign Portfolio Investor (Category - III)
- 0%
- 2,883
- Director or Director's Relatives
- 0%
- 1,150
- Employees
- 0%
- 121
- Others
- 0.31%
- 451,666
- Others
- 0.24%
- 348,418
- Others
- 0.23%
- 323,708
- Others
- 0.09%
- 131,345
- Others
- 0.05%
- 69,995
- Others
- 0%
- 1,398
- Others
- 0%
- 122
- Others
- 0%
- 4
- Promoter & Promoter Group Shareholding
- 29.33%
- 42,177,612
- M/s. PCR Investments Ltd
- 18.93%
- 27,223,124
- M/s. Indian Hospitals Corporation Ltd
- 0.04%
- 61,704
- M/s. Obul Reddy Investments Pvt Ltd
- 0.01%
- 11,200
- Ms. Suneeta Reddy
- 3.36%
- 4,834,305
- Ms. Sangita Reddy
- 1.69%
- 2,432,508
- Ms. Shobana Kamineni
- 1.56%
- 2,239,952
- Mr. K Vishweshwar Reddy
- 1.1%
- 1,577,350
- Ms. Preetha Reddy
- 0.73%
- 1,043,915
- Mr. Karthik Anand
- 0.24%
- 345,238
- Mr. Harshad Reddy
- 0.23%
- 327,900
- Ms. Sindoori Reddy
- 0.22%
- 318,600
- Ms. Anuspala Kamineni
- 0.18%
- 259,174
- Dr. Prathap C Reddy
- 0.17%
- 245,464
- Mr. Konda Anindith Reddy
- 0.16%
- 230,200
- Mr. Konda Vishwajit Reddy
- 0.15%
- 222,300
- Ms. Upasana Konidela
- 0.15%
- 217,276
- Mr. Puansh Kamineni
- 0.15%
- 212,201
- Ms. Sucharitha P Reddy
- 0.12%
- 169,800
- Mr. Konda Viraj Madhav Reddy
- 0.12%
- 168,224
- Mr. Dwaraknath Reddy
- 0.01%
- 18,000
- Mr. Aditya Reddy
- 0.01%
- 10,200
- Mr. Vijay Kumar Reddy
- 0.01%
- 8,957
- Mr. Anil Kamineni
- 0%
- 20
Shareholding Pattern
Shareholding Trend
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-Feb-23
- Quarterly Results
- 30-Nov-22
- Others
- 10-Nov-22
- Quarterly Results
- 11-Aug-22
- Quarterly Results
- 25-May-22
- Audited Results & Dividend
- 11-Feb-22
- Quarterly Results
- 12-Nov-21
- Quarterly Results
- 13-Aug-21
- Quarterly Results
- 23-Jun-21
- Audited Results & Dividend
- 12-Feb-21
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 31-Aug-21
- 22-Jul-21
- AGM
- 16-Aug-21
- 13-Jul-21
- POM
- 04-May-21
- 06-Apr-21
- POM
- -
- 25-May-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 25-May-22
- -
- 18-Aug-22
- 11.75
- 23-Jun-21
- -
- 18-Aug-21
- 3
Company Profile
ABOUT Apollo Hospitals Enterprise
- Industry Healthcare Facilities
- ISIN INE437A01024
- BSE Code 508869
- NSE Code APOLLOHOSP
Apollo Hospitals Enterprise Limited is an India-based company, which is engaged in providing comprehensive hospital services. The Company provides and sells pharma and wellness products through a network of pharmacies. The principal activities of the Company include the operation of multidisciplinary private hospitals, clinics and pharmacies. The Company operates through two segments: Healthcare and Retail Pharmacy. The Healthcare segment represents hospitals and hospital-based pharmacies. The Retail Pharmacy segment represents the business of procurement and distribution of pharmaceutical, fast-moving consumer goods (FMCG) and private label products. The Company has approximately 10209 beds across approximately 71 Hospitals, 24118 pharmacies in 20 states and four union territories.
MANAGEMENT
- Prathap Reddy Executive Chairman of the Board, Founder
- Shobana Kamineni Executive Vice Chairman of the Board
- Preetha Reddy Executive Vice Chairman of the Board
- Krishnan Akhileswaran Chief Financial Officer
- K. Hariprasad President - Hospitals
- Dinesh Madhavan President - Group Oncology and International
- S. M. Krishnan Senior Vice President - Finance, Compliance Officer, Company Secretary
- Sangita Reddy Joint Managing Director, Executive Director
- Suneeta Reddy Managing Director, Executive Director
- Anupam Sibal Group Medical Director
Company Summary
APOLLO HOSPITALS ENTERPRISE SUMMARY
Apollo Hospitals Enterprise is trading 0.29% upper at Rs 4245.20 as compared to its last closing price. Apollo Hospitals Enterprise has been trading in the price range of 4259.2 & 4158.95. Apollo Hospitals Enterprise has given -5.5% in this year & 0.17% in the last 5 days.
Apollo Hospitals Enterprise has TTM P/E ratio 75.07 as compared to the sector P/E of 39.92. There are 22 analysts who have initiated coverage on Apollo Hospitals Enterprise. There are 9 analysts who have given it a strong buy rating & 13 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 203.99 Crores in its last quarter.
Listed peers of Apollo Hospitals Enterprise include Apollo Hospitals Enterprise (0.29%), Max Healthcare Institute (-0.91%), Fortis Healthcare (-0.11%) etc.
Apollo Hospitals Enterprise has a 29.33% promoter holding & 70.67% public holding.
FAQs about Apollo Hospitals Enterprise
- 0 analysts have given a strong sell rating
- 0 analysts have given a sell rating
- 0 analysts have given a hold rating
- 13 analysts have given a buy rating
- 9 analysts have given a strong buy rating
- TTM P/E: 75.07
- Sector P/E: 39.92
- Dividend Yield: 0.28%
- D/E ratio: -